C-terminal truncation is a prominent post-translational modification of human erythrocyte α-synuclein

J Biochem. 2024 May 31;175(6):649-658. doi: 10.1093/jb/mvae012.

Abstract

α-Synuclein (α-Syn) is a protein related to synucleinopathies with high expression in the central nervous system and erythrocytes which are a major source of peripheral α-Syn. Recent reports have suggested the presence of α-Syn within extracellular vesicles (EVs) derived from erythrocytes, potentially contributing to the pathogenesis of synucleinopathies. While Lewy bodies, intracellular inclusions containing aggregated α-Syn, are prominently observed within the brain, their occurrence in peripheral neurons implies the dissemination of synucleinopathy pathology throughout the body via the propagation of α-Syn. In this study, we found erythrocytes and circulating EVs obtained from plasma contained α-Syn, which was separated into four major forms using high-resolution clear native-PAGE and isoelectric focusing. Notably, erythrocyte α-Syn was classified into full-length and C-terminal truncated forms, with truncation observed between Y133 and Q134 as determined by LC-MS/MS analysis. Our finding revealed that C-terminally truncated α-Syn, which was previously reported to exist solely within the brain, was also present in erythrocytes and circulating EVs obtained from plasma.

Keywords: Parkinson’s disease; extracellular vesicles; neurodegenerative disease; post-translational modification; α-synuclein.

MeSH terms

  • Erythrocytes* / metabolism
  • Extracellular Vesicles / metabolism
  • Humans
  • Protein Processing, Post-Translational*
  • Tandem Mass Spectrometry
  • alpha-Synuclein* / metabolism

Substances

  • alpha-Synuclein
  • SNCA protein, human

Grants and funding